{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:54:22Z","timestamp":1781020462437,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Transmission of the human immunodeficiency virus (HIV) among incarcerated injection drug users (IDU) is a health epidemic in the Islamic Republic of Iran. Triangular clinics (TCs) were established in prisons as a harm reduction measure to decrease the risk of HIV transmission and other blood-borne infections. The objective of this study was to assess the immediate outcomes of one TC among male IDUs in Iran\u2019s Rajaee-Shahr prison.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study was conducted in two stages between 2003 and 2005. In the preparatory stage, focus group data was collected to update the prison\u2019s TC education and medical interventions and construct the self-report questionnaire. In stage two, 150 male IDUs were recruited in a closed cohort study design to assess the immediate outcome of the TC. Participants were measured at baseline and followed up to six months to measure their drug use, attitude toward and knowledge of high risk behaviours, serological conversion for HIV, HBV and HCV, and engagement in risky behaviors. The TC outcomes were determined through random urine analysis testing, a self-administered questionnaire and behaviour report cards, and viral infection testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The findings of the urine analyses indicated a minimal yet consistent decrease in drug use over the six months. The pre and post- self-administered questionnaire data relayed a modest change in IDU risky behaviours associated with sexual practices; this was greater in comparison to the knowledge and attitude measures. It was determined that age may have a detrimental effect as may viral infections (HIV and HBV) on knowledge, attitude and behavior change. Both education and employment may have a protective effect. Data collected from the self-report behaviour cards similarly showed a modest reduction in high risk practices. At the six month follow-up, only one case became HIV positive, 9 HCV and 17 HBV.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Considering that HIV is concentrated among Iranian prisoners who inject drugs at a high level, the results of this study indicate that TCs are a possible effective intervention. However, many prisoners continued with risky behaviors even if they were participating in harm reduction measures, such as methadone maintenance therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7517-10-41","type":"journal-article","created":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T10:00:45Z","timestamp":1388052045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran"],"prefix":"10.1186","volume":"10","author":[{"given":"Rahim Taghizadeh","family":"Asl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Eshrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen Anne","family":"Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mirzazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,26]]},"reference":[{"key":"310_CR1","volume-title":"Annual report of drug control","author":"Drug Control Bureau","year":"2001","unstructured":"Drug Control Bureau: Annual report of drug control. 2001, Tehran"},{"key":"310_CR2","volume-title":"National Institute of Drug Abuse Conference","author":"S Momtazi","year":"2009","unstructured":"Momtazi S, Fallahnejad M, Shoghli A, Musavinasab N, Hajkarim B: Study of high-risk behaviors among injecting drug users in Iran. National Institute of Drug Abuse Conference. 2009"},{"key":"310_CR3","volume-title":"Islamic Republic of Iran AIDS Progress Report: On Monitoring of the United Nations General Assembly Special Session on HIV and AIDS","author":"National AIDS Committee Secretariat, Ministry of Health and Medical Education","year":"2012","unstructured":"National AIDS Committee Secretariat, Ministry of Health and Medical Education: Islamic Republic of Iran AIDS Progress Report: On Monitoring of the United Nations General Assembly Special Session on HIV and AIDS. 2012, Retrieved from: http:\/\/www.unaids.org\/en\/dataanalysis\/knowyourresponse\/countryprogressreports\/2012countries\/IRIran%20AIDS%20Progress%20Report%202012%20English%20final1_1.pdf"},{"key":"310_CR4","volume-title":"HIV\/AIDS in Iran (in Persian)","author":"Ministry of Health and Medical Education","year":"2007","unstructured":"Ministry of Health and Medical Education: HIV\/AIDS in Iran (in Persian). 2007, Tehran"},{"issue":"3","key":"310_CR5","first-page":"164","volume":"13","author":"A Mirzazadeh","year":"2007","unstructured":"Mirzazadeh A, Haghdoost A, Doostmohammadi P: Estimating the time trend of adjusted incidence of opioid dependency and multiple factors related to the lag time: backward calculation method. J Kerman Med Univ. 2007, 13 (3): 164-172.","journal-title":"J Kerman Med Univ"},{"key":"310_CR6","first-page":"1","volume-title":"Sex Transm Infect","author":"R Khajehkazemi","year":"2013","unstructured":"Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, Safaie A, Mostafavi E, Haghdoost A-A: HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 national surveillance survey. Sex Transm Infect. 2013, 1-4. 10.1136\/sextrans-2013-051204"},{"key":"310_CR7","first-page":"1","volume-title":"Sex Transm Infect J","author":"R Khajehkazemi","year":"2013","unstructured":"Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, Safaie A, Mostafavi E, Haghdoost A-A: HIV Prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Transm Infect J. 2013, 1-4. 10.1136\/sextrans-2013-051204"},{"key":"310_CR8","first-page":"1","volume-title":"Sex Transm Infect","author":"S Navadeh","year":"2013","unstructured":"Navadeh S, Mirzazadeh A, Mehdi Gouya M, Farnia M, Alasvand R, Haghdoost A-A: HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey. Sex Transm Infect. 2013, 1-4. doi: 10.1136\/sextrans-2013-051295"},{"key":"310_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/01.qai.0000219785.81163.67","volume":"42","author":"S Zamani","year":"2006","unstructured":"Zamani S, Kihara M, Gouya M: High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr. 2006, 42: 342-346. 10.1097\/01.qai.0000219785.81163.67.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"310_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s11524-010-9450-8","volume":"87","author":"S Zamani","year":"2010","unstructured":"Zamani S, Farnia M, Torknejad A, Alaei BA, Gholizadeh M, Kasaree F, Ono-Kihara M, Oba K, Kihara M: Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran. J Urban Health. 2010, 87 (4): 603-616. 10.1007\/s11524-010-9450-8. doi:10.1007\/s11524-010-9450-8","journal-title":"J Urban Health"},{"key":"310_CR11","volume-title":"The Majalla","author":"I Tanner","year":"2013","unstructured":"Tanner I: The Lion Chases Away the Dragon: Iran\u2019s drug treatment programs are among the world\u2019s most progressive. The Majalla. 2013, Retrieved from: http:\/\/www.majalla.com\/eng\/2013\/08\/article55244942"},{"key":"310_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.drugpo.2010.03.008","volume":"21","author":"M Farnia","year":"2010","unstructured":"Farnia M, Ebrahimi B, Shams A: Scaling up methadone maintenance treatment for opioid-dependent prisoners in in Iran. Int J Drug Policy. 2010, 21: 422-424. 10.1016\/j.drugpo.2010.03.008.","journal-title":"Int J Drug Policy"},{"key":"310_CR13","volume-title":"The New York Times: The Opinion Pages","author":"T Rosenberg","year":"2010","unstructured":"Rosenberg T: An Enlightened Exchange in Iran. The New York Times: The Opinion Pages. 2010, Retrieved from: http:\/\/opinionator.blogs.nytimes.com\/2010\/11\/29\/an-enlightened-exchange-in-iran\/"},{"key":"310_CR14","volume-title":"BBC News: Middle East","author":"F Harrison","year":"2004","unstructured":"Harrison F: Tackling Iran\u2019s growing drugs problem. BBC News: Middle East. 2004, Retrieved from: http:\/\/news.bbc.co.uk\/2\/hi\/4054703.stm"},{"key":"310_CR15","volume-title":"Triangular Clinic & Rehabilitation Centre","author":"United Nations Office on Drugs and Crime","year":"2006","unstructured":"United Nations Office on Drugs and Crime: Triangular Clinic & Rehabilitation Centre. 2006, Iran, Retrieved from: http:\/\/www.unodc.org\/treatment\/en\/Iran_resource_centre_11.html"},{"key":"310_CR16","volume-title":"TV News, The Canadian Press","author":"D Mehta","year":"2013","unstructured":"Mehta D: AIDS prevention groups want prison needle programs to protect inmates, public. TV News, The Canadian Press. 2013, Retrieved from: http:\/\/www.ctvnews.ca\/canada\/aids-prevention-groups-want-prison-needle-programs-to-protect-inmates-public-1.1502466"},{"key":"310_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1477-7517-5-21","volume":"5","author":"B Eshrati","year":"2008","unstructured":"Eshrati B, Taghizadeh R, Dell CA, Afshar P, Millson PME, Kamali M, Weekes J: Preventing HIV transmission among Iranian prisoners: initial support for providing education on the benefits of harm reduction practices. Harm Reduct J. 2008, 5: 21-10.1186\/1477-7517-5-21.","journal-title":"Harm Reduct J"},{"key":"310_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/09595239800187011","volume":"17","author":"S Lenton","year":"1998","unstructured":"Lenton S, Single E: The definition of harm reduction. Drug Alcohol Rev. 1998, 17: 213-220. 10.1080\/09595239800187011.","journal-title":"Drug Alcohol Rev"},{"key":"310_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1360-0443.1990.tb00649.x","volume":"85","author":"D Des Jarlais","year":"1990","unstructured":"Des Jarlais D: The public health paradigm for AIDS and the drug use: shifting the time frame. Br J Addict. 1990, 85: 348-349. 10.1111\/j.1360-0443.1990.tb00649.x.","journal-title":"Br J Addict"},{"key":"310_CR20","volume-title":"IPEDR","author":"A Shams","year":"2011","unstructured":"Shams A, Rabie N, Esmaili A, Baratvand M: The effect of the harm reduction approach in Iran\u2019s prisons. IPEDR. 2011, 20: Retrieved from: http:\/\/www.ipedr.com\/vol20\/37-ICHSC2011-M10018.pdf"},{"key":"310_CR21","volume-title":"World Drug Report Vienna: United Nations Office on Drugs and Crime","author":"UNODC","year":"2005","unstructured":"UNODC: World Drug Report Vienna: United Nations Office on Drugs and Crime. 2005"},{"key":"310_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1590\/S0102-311X2006000400025","volume":"22","author":"D Burrows","year":"2006","unstructured":"Burrows D: Advocacy and coverage of needle exchange programs: results of a comparative study of harm reduction programs in Brazil, Bangladesh, Belarus, Ukraine, Russian Federation, and China. Cad Saude Publica. 2006, 22: 871-879. 10.1590\/S0102-311X2006000400025.","journal-title":"Cad Saude Publica"},{"key":"310_CR23","volume-title":"Report on the Global AIDS Epidemic Annex 1: HIV and AIDS estimates and data, 2007 and 2001","author":"UNAIDS","year":"2008","unstructured":"UNAIDS: Report on the Global AIDS Epidemic Annex 1: HIV and AIDS estimates and data, 2007 and 2001. 2008, Geneva"},{"key":"310_CR24","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/j.1360-0443.2007.01914.x","volume":"102","author":"N Razani","year":"2007","unstructured":"Razani N, Mohraz M, Kheirandish P: HIV risk behavior among injection drug users in Tehran, Iran. Addiction. 2007, 102: 1472-1482. 10.1111\/j.1360-0443.2007.01914.x.","journal-title":"Addiction"},{"key":"310_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/IPC.0b013e318142ce16","volume":"15","author":"M Pourahmad","year":"2007","unstructured":"Pourahmad M, Javady A, Karimi I, Ataei B, Kassaeian N: Seroprevalence of and risk factors associated with hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners in Iran. Infect Dis Clin Pract. 2007, 15: 368-372. 10.1097\/IPC.0b013e318142ce16.","journal-title":"Infect Dis Clin Pract"},{"key":"310_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10461-008-9452-7","volume":"13","author":"H Fallahzadeh","year":"2009","unstructured":"Fallahzadeh H, Morowatisharifabad M, Ehrampoosh M: HIV\/AIDS epidemic features and trends in Iran, 1986\u20132006. AIDS Behav. 2009, 13: 297-302. 10.1007\/s10461-008-9452-7.","journal-title":"AIDS Behav"},{"issue":"4","key":"310_CR27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10461-008-9404-2","volume":"14","author":"S Zamani","year":"2010","unstructured":"Zamani S, Vazirian M, Nassirimanesh B: Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS Behav. 2010, 14 (4): 885-890. 10.1007\/s10461-008-9404-2.","journal-title":"AIDS Behav"},{"key":"310_CR28","first-page":"69","volume":"13","author":"N Ghanbarzadeh","year":"2006","unstructured":"Ghanbarzadeh N, Nadjafi Semnani M: A study of HIV and other sexually transmitted infections among female prisoners in Birjand. J Birjand Univ Med Sci. 2006, 13: 69-75.","journal-title":"J Birjand Univ Med Sci"},{"key":"310_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/aid.2008.0143","volume":"25","author":"M Ghannad","year":"2009","unstructured":"Ghannad M, Arab S, Mirzaei M, Moinipur A: Epidemiologic study of human immunodeficiency virus (HIV) infection in the patients referred to health centers in Hamadan Province, Iran. AIDS Res Hum Retrov. 2009, 25: 277-283. 10.1089\/aid.2008.0143.","journal-title":"AIDS Res Hum Retrov"},{"issue":"14","key":"310_CR30","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1016\/j.ijid.2009.03.002","volume":"14","author":"A Rahimi-Movaghar","year":"2010","unstructured":"Rahimi-Movaghar A, Razaghi E, Sahimi-Izadian E, Amin-Esmaeili M: HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infec Dis. 2010, 14 (14): e28-e33.","journal-title":"Int J Infec Dis"},{"issue":"3","key":"310_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.drugpo.2009.03.001","volume":"21","author":"S Zamani","year":"2010","unstructured":"Zamani S, Farnia M, Tavakoli S: A qualitative inquiry into methadone maintenance treatmenmt for opiod-dependent prisoners in Tehran, Iran. Int J Drug Policy. 2010, 21 (3): 167-172. 10.1016\/j.drugpo.2009.03.001.","journal-title":"Int J Drug Policy"},{"key":"310_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1477-7517-6-21","volume":"6","author":"H Rafiey","year":"2009","unstructured":"Rafiey H, Narenjiha H, Shirinbayan P: Needle and syringe sharing among Iranian drug injectors. Harm Reduct J. 2009, 6: 21-10.1186\/1477-7517-6-21.","journal-title":"Harm Reduct J"},{"key":"310_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/jinf.2000.0647","volume":"40","author":"A Taylor","year":"2000","unstructured":"Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, Green S, Pithie A, Fox R: Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990\u20131996: are current harm reduction strategies working?. J Infect. 2000, 40: 176-183. 10.1053\/jinf.2000.0647.","journal-title":"J Infect"},{"key":"310_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-7517-2-19","volume":"2","author":"M Vazirian","year":"2005","unstructured":"Vazirian M, Nassirimanesh B, Zamani S: Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduct J. 2005, 2: 19-10.1186\/1477-7517-2-19.","journal-title":"Harm Reduct J"},{"key":"310_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1477-7517-1-8","volume":"1","author":"T Ruefli","year":"2004","unstructured":"Ruefli T, Rogers SJ: How do drug users define their progress in harm reduction programs? Qualitative research to develop user-generated outcomes. Harm Reduct J. 2004, 1: 8-10.1186\/1477-7517-1-8.","journal-title":"Harm Reduct J"},{"key":"310_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jana.2009.03.003","volume":"20","author":"A Mohammadpour","year":"2009","unstructured":"Mohammadpour A, Yekta ZP, Nikbakht Nasrabadi AR, Mohraz M: Coming to terms with a diagnosis of HIV in Iran: a phenomenological study. J Assoc Nurses AIDS Care. 2009, 20: 249-259. 10.1016\/j.jana.2009.03.003.","journal-title":"J Assoc Nurses AIDS Care"},{"key":"310_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/sti.2004.011114","volume":"81","author":"MR Jahani","year":"2005","unstructured":"Jahani MR, Alavian SM, Shirzad H, Kabir A, Hajarizadeh B: Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with \u201cillegal social behavior\u201d. Sex Transm Infect. 2005, 81: 185-","journal-title":"Sex Transm Infect"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7517-10-41.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:28:24Z","timestamp":1630549704000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/1477-7517-10-41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1186\/1477-7517-10-41","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"19 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}